Silymarin and Vanillic Acid Silver Nanoparticles Alleviate the Carbon Tetrachloride-Induced Nephrotoxicity in Male Rats

El Rabey, Haddad A.; Alamri, Eman S.; Alzahrani, Othman R.; Salah, Nouran M.; Attia, Eman S.; Rezk, Samar M.

doi:https://doi.org/10.1155/2023/4120553

International Journal of Polymer Science

On this page

Abstract Introduction Materials and Methods Results and Discussion Conclusion Abbreviations Data Availability Conflicts of Interest Supplementary Materials References Copyright Related Articles

Research Article | Open Access

Volume 2023 | Article ID 4120553 | https://doi.org/10.1155/2023/4120553

Silymarin and Vanillic Acid Silver Nanoparticles Alleviate the Carbon Tetrachloride-Induced Nephrotoxicity in Male Rats

Haddad A. El Rabey,^1,2Eman S. Alamri,³Othman R. Alzahrani,⁴Nouran M. Salah,⁵Eman S. Attia,⁶and Samar M. Rezk⁷

Academic Editor: Ahmed Tayel

Received05 Jan 2023

Revised16 Jan 2023

Accepted27 Jan 2023

Published02 Feb 2023

Abstract

Natural copolymer (e.g., chitosan-loaded) and synthetic (e.g., silver nitrate-loaded) nanopolymers have many medical applications in drug delivery research for enhancing the effectuality of traditional medicine. This study aimed to investigate the potential protective activity of vanillic acid, silver nanoparticles (AgNPs) of vanillic acid, and silymarin against carbon tetrachloride (CCl₄)-induced nephrotoxicity in male rats. Rats were divided into five groups; the first group (G1) was a negative control, and the other rats were treated intraperitoneally with CCl₄ to induce kidney toxicity twice weekly, and then divided into four groups, G2 was a positive control and left without treatment, the third group was treated with vanillic acid, the fourth (G4) was treated with vanillic acid-AgNPs, and the fifth (G5) was treated with silymarin. In G2, renal function indices (urea, creatinine, and uric acid) showed elevated levels indicating renal toxicity. Na, K, and Ca ions were decreased, whereas Cl⁻ was increased. Antioxidants (glutathione S-transferase, glutathione reduced, total antioxidant capacity, superoxide dismutase, and catalase) were decreased, whereas lipid peroxidation was increased in the kidney tissue homogenate. IL1 was increased, whereas CYP-450 was decreased. In the treated group, all biochemical and renal tissue texture were alleviated as a result of treatment with vanillic acid in G3, vanillic acid AgNPs in G4, and silymarin in G5. Vanillic acid AgNPs and silymarin treatment in G4 and G5, respectively, were more efficient than vanillic acid in G5 in protecting the kidneys against CCl₄-induced nephrotoxicity.

1. Introduction

The kidneys balance blood water and electrolyte levels, manage blood pressure, influence blood cell production, adjust the acid–base balance, keep electrolyte concentration, and make the active form of vitamin D; however, when one or both kidneys are acutely or chronically injured they will lose their filtration ability and causes nausea, fatigue, vomiting, and brain fog [1, 2].

Glycerol is commonly used to induce acute kidney disease in model animals [3, 4]; however, other drugs may also induce kidney diseases, such as high doses of acetaminophen (2000 mg/kg body weight) [5], cisplatin at an intravenous dose of 30 mg/m² daily for 7 days induced kidney failure in goats [6], adenine at a dose of 0.75% adenine in the diet of rats for 4 weeks [7], and aristolochic acid nephropathy was also used to induce chronic kidney disease in mice [8]. In addition, a single high dose of cisplatin, which is used for treating solid tumors induced nephrotoxicity [9].

The natural products present are the active constituents of the herbal medicine that were effective in treating kidney disease in humans and experimental animals and in vitro studies [1, 2]. In addition, herbal medicine is commonly used today as an alternative therapy because of its low-cost price compared with traditional medical therapy and its minimal toxicity, which makes medicinal plants occupy a great position [10–12]. Herbal medicine appeared great benefits in nephroprotection to protect kidneys against different types of injuries to avoid dialysis or transplantation, which are the main treatment methods nowadays [13, 14]. On the other hand, incorporating vegetables and fruits rich in antioxidants in the diet improves kidney health and delays chronic kidney failure by reducing inflammation and hampering reactive oxygen species (ROS) formation [15, 16].

The phenolic derivative—vanillic acid (4-hydroxy-3-methoxy benzoic acid)—is an intermediate in the production of vanillin from ferulic acid and showed medicinal activities due to its antioxidant potential as an antibacterial [17], antihypertensive and antioxidant [18], nephroprotective effect [19], anticancer [20], protecting against acetaminophen-induced hepatotoxicity in rats [21], and protecting against carbon tetrachloride (CCl₄)-induced hepatotoxicity [12].

The biomedical application of silver nanoparticles (AgNPs) has been flourished in the last decades because of their specific biological, physical, and chemical properties; besides, their low cost and high efficiency in drug delivery purposes [12, 21–23]. They raised the efficiency of the pharmacokinetics and pharmacodynamics of drugs by enhancing the action of therapeutic agents and developed their specific and selective delivery system that positively affected human healthcare practice; therefore, researchers advocated developing their design and inventing new systems for drug delivery [24, 25]. They are applied in multifunction drug delivery systems [26]. AgNPs also succeeded in inhibiting vancomycin resistance in Staphylococcus aureus [27]. In addition, polymeric nanomaterial therapy using natural polymers, such as chitosan, which is produced by the deacetylation of chitin, and biosynthetic AgNPs have been recommended for nanomedical and biomedical applications [28]. Bee venom polymers like fungal chitosan-loaded nanoparticles conferred significant activity against cervix carcinoma [29].

Silymarin is an antioxidant, anti-inflammatory, and hepatoprotective agent obtained from Silybum marianum [12, 30, 31]. Its protection effect is thanks to several activities, such as cell permeability regulator, and membrane stabilizer, antioxidant, anti-inflammatory, inhibiting the deposition of collagen fibers and stimulating liver regeneration [31]. Silymarin has the ability to ameliorate diabetic nephropathy that results from the generation of ROS and the overproduction of superoxide, initiating podocyte injury and leading to the pathogenesis of diabetic kidney disease [32, 33]. Silymarin could protect the kidneys against iron deposition in the kidneys of animal models [34, 35]. It was also effective in protecting mice against renal ischemia–reperfusion injury [36].

The current study aimed to test the probable nephrotoxic effect of CCl₄ as well as the protective effect of vanillic acid, vanillic acid AgNPs, and silymarin against this CCl₄-nephrotoxicity in male rats.

2. Materials and Methods

2.1. Chemicals and Kits

The chemicals of this study are of analytical grades and were purchased from Sigma–Aldrich (Missouri, USA) unless designated to other sources. Olive oil was obtained from a local market and silymarin was purchased from a pharmacy. Kits were purchased from different suppliers and were used according to the instruction of the suppliers.

2.1.1. Synthesis of AgNPs from Vanillic Acid

A photo-mediated method for reducing silver ions was used in synthesizing silver nitrate nanoparticles of vanillic acid (AgNPs) as described by Zamani and Moradshahi [37] and Alamri et al. [12] as follows: A 2 g vanillic acid quantity was dissolved in a small volume of ethanol and completed to 100 mL by distilled water. Twenty milligrams of silver nitrate was added and mixed with a magnetic stirrer. The pH of the mixture was adjusted to 10.0. A noticeable color change from colorless to yellow to dark brown was encountered that confirm the formation of the AgNPs [12, 37].

2.1.2. Characterization of AgNPs

(1) Examination of the Synthesized Vanillic Acid Nanoparticles under Ultraviolet–Visible Spectroscopy. The AgNPs surface plasmon resonance (SPR) was detected by measuring the UV–Vis spectra of the synthesized particles using a UVS-85 spectrophotometer spanning the range of 300–800 nm [12, 38].

(2) Examination of the Synthesized Nanoparticles under Transmission Electron Microscope. The synthesized vanillic acid AgNPs size, morphology, form, purity, and assembly were examined by transmission electron microscopy (TEM, Jeol JEM-1400, Jeol Ltd., Tokyo, Japan) as follows: a 2–5 μL droplets samples were placed onto a parafilm sheet, the grids (carbon-coated 400-mesh copper grids) of the sample were created, and then swept off by filter paper. Finally, the grids were inserted into the petri dish of the sample [12, 39].

(3) Size Determination and Distribution Using Dynamic Light Scattering. To determine the size and the distribution peak of size within the range of the synthesized vanillic acid AgNPs the AgNPs were dispersed in a liquid sample and then estimated using the NICOMP Nano ZLS (Z3000 zls) particle sizing device (Entegris, Dresden, Germany). The size of the synthesized AgNPs was calculated using dynamic light scattering (DLS). Before analysis, samples of the synthesized vanillic acid AgNPs were diluted ten times in deionized water, a volume of 250 μL was transferred to a cuvette, and then equilibrated at 20°C for 2 minutes [12, 40].

2.2. Animals and Experiment Design

Thirty Sprague Dawley rats were purchased from the Faculty of Pharmacy, Mansoura University, Mansoura, Egypt, and used under the approved ethical regulations of Animal houses of Mansoura University (approval code, 0184). The rats were kept under observation for two weeks for acclimatization under standardized laboratory conditions. Food and water were given ad libitum during the experiment span. After acclimatization, the rats were divided into five groups as follows: the first group was the negative control group (G1) received only olive oil in water (1 : 1) intraperitoneally on the first and fourth day every week during the experiment that extended for four weeks, and the other rats were treated intraperitoneally treated with CCl₄ in olive oil (1 : 1) twice weekly on the first and the fourth day to induce kidney toxicity [30], and then divided into four groups, the second group (G2) was a positive control and left without treatment, the third group (G3) was treated with vanillic acid (100 mg/g body weight), the fourth group (G4) was treated with vanillic acid AgNPs [18], and the fifth group (G5) was treated with silymarin (50 mg/kg body weight) [31].

2.3. Blood Collection

By the end of the experiment, the rats were anesthetized by diethyl ether and blood samples were collected, centrifuged for 5 minutes at 3000 rpm, and then the plasma was transferred into new tubes for biochemical analyses.

2.4. Preparation of Kidney Homogenate

One kidney was dissected out, washed with saline solution, kept ice cold and homogenized in ice-cold phosphate buffer (pH 7.4), and then centrifuged at 4000 rpm for 15 minutes. The supernatant was used in the determination of total antioxidant capacity (TAC), antioxidant enzymes, and lipid peroxidation.

2.5. Biochemical Analysis

Kidney function indices, such as creatinine, urea, and uric acid were determined in serum using Human Diagnostic Kit (Wiesbaden, Germany). Serum electrolytes, such as sodium, potassium, calcium, and chlorine ions were measured using Human Diagnostic Kit. Interleukin-1 (IL-1) was determined using MyBioSource Kit (San Diego, CA, USA), whereas cytochrome P-450 (CYP-450) was determined using Abbexa Kit from Cambridge, UK. All analyses were done according to the instructions of the suppliers. Biodiagnostic Kit (Cairo, Egypt) was used for the estimation of antioxidants [superoxide dismutase (SOD), catalase (CAT), glutathione reduced (GSH), and glutathione S-transferase (GST)] and TAC in the kidney tissue homogenate. Biodiagnostic Kit was also used in the estimation of lipid peroxidation as revealed by malondialdehyde (MDA) in the kidney tissue homogenate. All analyses were achieved according to the method described by the supplier.

2.6. Histological Study

The kidney tissue was immediately fixed in 10% formalin, dehydrated in ethanol (70%, 80%, and 90%), cleared in xylene, embedded in paraffin, and then sectioned by microtome. The sections were then stained with hematoxylin–eosin (H&E) according as described by Bancroft and Stevens [41].

2.7. Statistical Analysis

Data were analyzed using the statistical package (SPSS) program, version 17.0 [42] and presented as mean ± standard error, and reanalyzed by the one-way analysis of variance (ANOVA statistical measure) using Duncan’s test for comparison of significance between groups.

3. Results and Discussion

3.1. Synthesis and Characterization of AgNPs

The emergence of dark brown color in the vanillic acid solution following the addition of silver nitrate confirmed AgNP synthesis [37, 43]. The proper synthesis of the reduced AgNPs of vanillic acid in the solution was visualized under UV–Vis spectrum, which is one of the most important ways for confirming the synthesis of AgNPs shows that the synthesized metal nanoparticles exhibited SPR and their characteristic SPR band occurred at 450 nm as seen in Figure 1 [44, 45]. This result is consistent with that of Ashraf et al. [46], they stated that the AgNPs exhibit a maximum UV–Visible absorption in the range of 400–500 nm thanks to the SPR. In addition, Alamri et al. [12] reported that the maximum absorption was 450 nm.

On the other hand, Figure 2 shows the TEM image of the vanillic acid AgNPs showing a spherical shape with a diameter ranging from 12.1 to 15.3 nm [12, 39]. In addition, the synthesized vanillic acid AgNPs were seen based on the electron plasmon oscillations of their free surface as seen by the UV–Vis spectra. Moreover, the shape and size of the synthesized vanillic acid AgNPs peaks in the spectra are due to the (SPR peaks. In addition, locating the peaks at 450 nm confirmed that there was no significant difference in the size of the synthesized vanillic acid AgNPs [12, 39]. In addition, the result of the DLS analysis (Figure 3) shows that the synthesized vanillic acid AgNPs has an average particle size of 21.6 nm [12, 40].

3.2. Effect of CCl₄-Induced Nephrotoxicity on Renal Function Indices

Table 1 shows the effect of treating CCl₄-induced nephrotoxicity in male rats with vanillic acid, vanillic acid AgNPs, and silymarin on kidney function indices: serum creatinine, serum urea, and serum uric acid. The CCl₄-induced nephrotoxicity in the positive control (G2) significantly increases all kidney function indices compared with that of the negative control [30, 31]. While treating the nephrotoxic rats with vanillic acid, vanillic acid AgNPs, and silymarin in G3, G4, and G5, respectively, greatly ameliorated the altered renal parameters and nearly restored them to normal levels. Vanillic acid treatment in G3 and the AgNPs vanillic acid in G4 greatly ameliorated the altered kidney indices due to the antioxidant activity of vanillic acid conferred by its methoxy group [12, 17, 19, 21]. The treatment with AgNPs of vanillic acid in G4 was more effective than vanillic acid in G3 [12, 21, 22]. In addition, the treatment with silymarin in G5 was more effective than the other groups. Silymarin is known for its protective activity as an antioxidant and anti-inflammatory activity [35]. The current result is consistent with that of Rafieian-Kopaie and Nasri [30], they stated that silymarin prevents diabetic nephropathy. In addition, the result of the current study showed that the biosynthetic polymeric vanillic acid AgNPs increased the protecting activity of vanillic acid [27–29].

3.3. Effect of CCl₄-Induced Nephrotoxicity on Serum Electrolytes

The concentration of serum positive ions of sodium, potassium, and calcium was decreased, whereas the negative chlorine ions concentration was increased as a result of CCl₄-induced nephrotoxicity in the positive control group as shown in Figures 4a, 4b, 4c, and 4d and Supplemental Table S1 [30, 31]. However, this altered ions concentration was nearly restored after treatment with vanillic acid, vanillic acid AgNPs, and silymarin in G3, G4, and G5, respectively. Vanillic acid and vanillic acid AgNPs succeeded to restore the altered Na, K, Ca, and Cl ions due to the antioxidant effect of vanillic acid that reflected in restoring the kidney function parameters [19, 30]. The altered ions concentration was efficiently restored by silymarin treatment in G5 compared with vanillic acid in G3 and vanillic acid AgNPs in G4 thanks to the highly protecting and anti-inflammatory effects of silymarin to tissues that restored their normal functions [12, 30, 31].

(a)

(b)

(c)

(d)

3.4. Effect of CCl₄-Induced Nephrotoxicity on Antioxidants and Total Antioxidant Capacity

Table 2 shows the effect of treating CCl₄-induced nephrotoxicity in male rats with vanillic acid, vanillic acid AgNPs, and silymarin on antioxidants (GST, GSH, SOD, and CAT) and TAC [30, 31]. All antioxidant enzymes and TAC were decreased in the kidney tissue homogenate as a result of CCl₄-induced nephrotoxicity in the positive control group (G2) compared with the negative control [12]. Rats of the treated groups G3, G4, and G5 showed significant protection and the antioxidant enzyme activity and the TAC were increased, especially in the fourth and fifth groups that were treated with vanillic acid AgNPs and silymarin [12, 21, 31, 35].

3.5. Effect of CCl4-Induced Nephrotoxicity on Lipid Peroxidation as Revealed by MDA Level

In the positive control group (G2), lipid peroxidation as revealed by MDA level in the kidney tissue homogenate was increased as a result of CCl₄-induced nephrotoxicity in comparison with that of the negative control as shown in Figure 5 and Supplemental Table S2 [30, 31]. On the other hand, lipid peroxidation level was decreased with vanillic acid, vanillic acid AgNPs, and silymarin treatment in G3, G4, and G5, respectively, compared with that of the positive control. Treating with vanillic acid AgNPs and silymarin in G4 and G5 were more efficient than vanillic acid in G3 [12, 35].

3.6. Effect of CCl4-Induced Nephrotoxicity on IL-1 and CYP-450 Levels

Serum IL-1 level was increased, whereas CYP-450 level was decreased as a result of CCl4-induced nephrotoxicity in the positive control group (G2) compared with that of the negative control (G1) as shown in Figures 6(a) and 6(b) and Supplemental Table S3. This result is consistent with that of El Rabey et al. [31]. The levels of IL-1 and CYP-450 were nearly restored to the normal values in G1 with treatment with vanillic acid in G3, vanillic acid AgNPs in G4, and silymarin in G5 [12]. In addition, silymarin was more effective than vanillic acid and vanillic acid AgNPs [12, 31, 35].

(a)

(b)

3.7. Histopathology

Figure 7(a) shows the normal renal tissue of the negative control revealing the normal histological structure of renal parenchyma, normal renal tissue, normal blood vessels, and interstitial with no histopathological changes and normal composition and normal blood vessels. The glomeruli were normal in structure and pattern, and the renal tubules were normal lining epithelium. In the second group G2 (the positive control group) the renal cortical tissue showed glomerular ischemia with shrinkage of vascular tuft, marked tubular atrophy, and moderate interstitial mononuclear inflammatory infiltrate as shown in Figure 7(b). This result is consistent with Elbakry et al. [30] and El Rabey et al. [31], they reported CCl₄-induced nephrotoxicity and with other studies confirming histological damage as a result of CCI₄-induced nephrotoxicity. In G3, which was treated with vanillic acid, the renal cortical tissue showed moderate glomerular ischemia, moderate tubular atrophy, and mild interstitial inflammation (Figure 7(c)). Figure 7(d) shows nearly normal renal tissues of G4 with nearly normal renal cortical tissue with mild glomerular ischemia, mild tubular atrophy, and minimal interstitial infiltrate. In G5, the renal tissues showed nearly normal cortical tissue with only very mild tubular atrophy (Figure 7(e)). Herbal active constituents, such as vanillic acid protected against nephrotoxic effects [15, 21]. In addition, the biosynthesis of vanillic acid in G4 showed more effective protection than vanillic acid in G3 [28, 29]. Due to its highly protective and anti-inflammatory effects, silymarin was used in protecting against a variety of hepatotoxic and nephrotoxic agents [12, 30, 31, 35].

(a)

(b)

(c)

(d)

(e)

4. Conclusion

In the current study, the nephrotoxic effect of CCl₄ was confirmed as revealed by the altered kidney function indices, electrolyte concentrations, antioxidant, lipid peroxidation, IL-1, CYP-450, and the injured kidney tissues. The biosynthetic vanillic acid, vanillic acid AgNPs, and silymarin were used in treating the induced CCl₄-nephrotoxicity in male rats. Vanillic acid showed a moderate protective effect against the CCl₄-induced nephrotoxicity compared with vanillic acid AgNPs and silymarin, which showed higher protection by nearly restoring both the biochemical and histological changes nearly to the normal state. In addition, silymarin showed the highest protection compared with vanillic acid and vanillic acid AgNPs. More studies are needed for an in-depth understanding of the exact nephrotoxic effects of CCl₄ and the exact protecting action of vanillic acid AgNPs and silymarin in protecting against CCl4-induced nephrotoxicity.

Abbreviations

AAN:	Aristolochic acid nephropathy
AgNPs:	Silver nanoparticles
CAT:	Catalase
CYP-450:	Cytochrome P-450
DLS:	Dynamic light scattering
G1:	A negative control group was intraperitoneally injected with 1 : 1 water to olive oil on the first and fourth day of every week
G2:	A positive control group was intraperitoneally injected with 1 : 1 CCl₄ to olive oil on the first and fourth day of every week and left without treatment
G3:	Intraperitoneally injected with 1 : 1 CCl₄ to olive oil on the first and fourth day of every week and was treated with vanillic acid
G4:	Intraperitoneally injected with 1 : 1 CCl₄ to olive oil on the first and fourth day of every week and was treated with vanillic acid silver nanoparticles
G5:	Intraperitoneally injected with 1 : 1 CCl₄ to olive oil on the first and fourth day of every week and was treated with silymarin
GSH:	Glutathione reduced
GST:	Glutathione-S-transferase
IL-1:	Interleukin-1
MDA:	Malondialdehyde
ROS:	Reactive oxygen species
SOD:	Superoxide dismutase
TAC:	Total antioxidant capacity.

Data Availability

Data supporting this research article are available from the corresponding author on reasonable request.

Conflicts of Interest

The author(s) declare(s) that they have no conflicts of interest.

Acknowledgment

The authors extend their appreciation to the Deanship of Scientific Research at University of Tabuk for funding this work through research project no. 0178-S-1442.

Supplementary Materials

Table S1. Effect of treating CCl₄-induced nephrotoxicity in male rats vanillic acid, vanillic acid AgNPs, and silymarin on serum electrolytes levels. Table S2. Effect of treating CCl₄-induced nephrotoxicity in male rats with vanillic acid, vanillic acid AgNPs, and silymarin on malonaldehyde (MDA). Table S3. Effect of treating CCl₄-induced nephrotoxicity in male rats with vanillic acid, vanillic acid AgNPs, and silymarin on serum IL-1 and CYP-450 levels. (Supplementary Materials)

References

Z. Khan, M. Pandey, and R. M. Samartha, “Role of cytogenetic biomarkers in management of chronic kidney disease patients: a review,” International Journal of Health Sciences, vol. 10, pp. 576–581, 2016.
View at: Google Scholar
P. Borkar, V. Yadav, R. R. Tiwari, and R. M. Samarth, “A systematic review of potential candidates of herbal medicine in treatment of chronic kidney disease,” Phytomedicine Plus, vol. 2, no. 4, p. 100361, 2022.
View at: Publisher Site | Google Scholar
V. R. Konda, R. Arunachalam, M. Eerike et al., “Nephroprotective effect of ethanolic extract of Azima tetracantha root in glycerol induced acute renal failure in Wistar albino rats,” Journal of Traditional and Complementary Medicine, vol. 6, no. 4, p. 347, 2015.
View at: Google Scholar
A. K. Al Asmari, K. T. Al Sadoon, A. A. Obaid et al., “Protective effect of quinacrine against glycerol-induced acute kidney injury in rats,” BMC Nephrology, vol. 18, no. 1, p. 41, 2017.
View at: Publisher Site | Google Scholar
S. Roy, S. Pradhan, K. Das et al., “Acetaminophen induced kidney failure in rats: a dose response study,” Journal of Biological Sciences, vol. 15, no. 4, pp. 187–193, 2015.
View at: Publisher Site | Google Scholar
A. Mishra, U. S. Chatterjee, and T. K. Mandal, “Cisplatin: a new animal model,” Toxicology International, vol. 20, no. 1, pp. 56–60, 2013.
View at: Publisher Site | Google Scholar
V. Diwan, L. Brown, and G. C. Gobe, “Adenine-induced chronic kidney disease in rats,” Nephrology, vol. 23, no. 1, pp. 5–11, 2018.
View at: Publisher Site | Google Scholar
L. Huang, A. Scarpellini, M. Funck, E. A. M. Verderio, and T. S. Johnson, “Development of a chronic kidney disease model in C57BL/6 mice with relevance to human pathology,” Nephron Extra, vol. 3, no. 1, pp. 12–29, 2013.
View at: Publisher Site | Google Scholar
R. Acar, N. Karadurmus, and B. Koc, “Analysis of tissue cytokine levels in rats with cisplatin-induced experimental nephrotoxicity,” Eurasian Journal of Medical Investigation, vol. 4, no. 3, pp. 376–379, 2020.
View at: Publisher Site | Google Scholar
M. N. Al-Seeni, H. A. El Rabey, A. M. Al-Hamed, and M. A. Zamazami, “Nigella sativa oil protects against tartrazine toxicity in male rats,” Toxicology Reports, vol. 5, pp. 146–155, 2018.
View at: Publisher Site | Google Scholar
H. A. El Rabey, F. M. Almutairi, A. I. Alalawy et al., “Augmented control of drug-resistant Candida spp. via fluconazole loading into fungal chitosan nanoparticles,” International Journal of Biological Macromolecules, vol. 141, pp. 511–516, 2019.
View at: Publisher Site | Google Scholar
E. S. Alamri, H. A. El Rabey, O. R. Alzahrani et al., “Enhancement of the protective activity of vanillic acid against tetrachloro-carbon (CCl₄) hepatotoxicity in male rats by the synthesis of silver nanoparticles (AgNPs),” Molecules, vol. 28–27, no. 23, p. 8308, 2022.
View at: Google Scholar
R. M. Samarth, M. Samarth, and Y. Matsumoto, “Medicinally important aromatic plants with radioprotective activity,” Future Science OA, vol. 3, no. 4, p. FSO247, 2017.
View at: Publisher Site | Google Scholar
J. Huang, Y. Zhang, L. Dong et al., “Ethnopharmacology, phytochemistry, and pharmacology of Cornus officinalis Sieb. et Zucc,” Journal of Ethnopharmacology, vol. 213, pp. 280–301, 2018.
View at: Publisher Site | Google Scholar
J. J. Carrero, A. González-Ortiz, C. M. Avesani et al., “Plant-based diets to manage the risks and complications of chronic kidney disease,” Nature Reviews Nephrology, vol. 16, no. 9, pp. 525–542, 2020.
View at: Publisher Site | Google Scholar
M. Zhao, Y. Yu, R. Wang et al., “Mechanisms and efficacy of Chinese herbal medicines in chronic kidney disease,” Frontiers in Pharmacology, vol. 11, p. 619201, 2021.
View at: Publisher Site | Google Scholar
R. Yadav, D. Saini, and D. Yadav, “Synthesis and evaluation of vanillin derivatives as antimicrobial agents,” Turkish Journal of Pharmaceutical Sciences, vol. 15, no. 1, pp. 57–62, 2018.
View at: Publisher Site | Google Scholar
S. Kumar, P. Prahalathan, and B. Raja, “Antihypertensive and antioxidant potential of vanillic acid, a phenolic compound in L-NAME-induced hypertensive rats: a dose-dependence study,” Redox Reports, vol. 16, no. 5, pp. 208–215, 2011.
View at: Publisher Site | Google Scholar
G. Sindhu, E. Nishanthi, and R. Sharmila, “Nephroprotective effect of vanillic acid against cisplatin induced nephrotoxicity in Wistar rats: a biochemical and molecular study,” Environmental Toxicology and Pharmacology, vol. 39, no. 1, pp. 392–404, 2015.
View at: Publisher Site | Google Scholar
H. Tsuda, N. Uehara, Y. Iwahori et al., “Chemopreventive effects of beta-carotene, alpha-tocopherol and five naturally occurring antioxidants on initiation of hepatocarcinogenesis by 2-amino-3-methylimidazo [4, 5] quino line in the rat,” Japanese Journal of Cancer Research, vol. 85, no. 12, pp. 1214–1219, 1994.
View at: Publisher Site | Google Scholar
B. Raja and M. S. Deepa, “The protective role of vanillic acid against acetaminophen-induced hepatotoxicity in rats,” Journal of Pharmacology Research, vol. 3, pp. 1480–1484, 2010.
View at: Google Scholar
P. Mathur, S. Jha, S. Ramteke, and N. K. Jain, “Pharmaceutical aspects of silver nanoparticles,” Artificial Cells, Nanomedicine, and Biotechnology, vol. 46, no. sup 1, pp. 115–126, 2018.
View at: Publisher Site | Google Scholar
G. Ioana and D. Cristea, “Silver nanoparticles for delivery purposes,” Nanoengineered Biomaterials for Advanced Drug Delivery, Elsevier, pp. 347–371, 2020.
View at: Google Scholar
W. Park and K. Na, “Advances in the synthesis and application of nanoparticles for drug delivery,” Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology, vol. 7, no. 4, pp. 494–508, 2015.
View at: Publisher Site | Google Scholar
H. Jahangirian, E. G. Lemraski, T. J. Webster et al., “A review of drug delivery systems based on nanotechnology and green chemistry: green nanomedicine,” International Journal of Nanomedicine, vol. 12, pp. 2957–2978, 2017.
View at: Publisher Site | Google Scholar
M. Younas, M. A. Ahmad, F. T. Jannat, T. Ashfaq, and A. Ahmad, “Chapter 18, role of silver nanoparticles in multifunctional drug,” in Nanomedicine Manufacturing and Applications, pp. 298–319, Elsevier, 2021.
View at: Publisher Site | Google Scholar
N. Mahmoud, A. Saafan, E. Salem et al., “Inhibition of the vancomycin resistance in Staphylococcus aureus in Egypt using silver nanoparticles,” BioMed Research International, vol. 2, p. 10, 2022.
View at: Publisher Site | Google Scholar
P. A. Mistry, M. N. Konar, S. Latha et al., “Chitosan superabsorbent biopolymers in sanitary and hygiene applications,” International Journal of Polymer Science, vol. 2020, Article ID 2785304, 2023.
View at: Google Scholar
A. I. Alalawy, H. A. El Rabey, F. M. Almutairi et al., “Effectual anticancer potentiality of loaded bee venom onto fungal chitosan nanoparticles,” International Journal of Polymer Science, vol. 2020, Article ID 2785304, 2020.
View at: Google Scholar
M. A. Elbakry, H. A. El Rabey, W. Elremaly et al., “The methanolic extract of Moringa oleifera attenuates CCl₄ induced hepatonephro toxicity in the male rat,” Biomedical Research, vol. 30, no. 1, pp. 23–31, 2019.
View at: Publisher Site | Google Scholar
H. El Rabey, S. M. Rezk, M. I. Sakran et al., “Green coffee methanolic extract and silymarin protect against CCl₄-induced hepatotoxicity in albino male rats,” BMC Complementary Medicine and Therapies, vol. 21, no. 1, p. 19, 2021.
View at: Publisher Site | Google Scholar
M. Rafieian-Kopaie and H. Nasri, “Silymarin and diabetic nephropathy,” Journal of Renal Injury Prevention, vol. 1, no. 1, pp. 3–5, 2012.
View at: Publisher Site | Google Scholar
M. Tavafi, “Complexity of diabetic nephropathy pathogenesis and design of investigations,” Journal of Renal Injury Prevention, vol. 2, no. 2, pp. 61–65, 2013.
View at: Google Scholar
M. Nematbakhsh, Z. Pezeshki, B. Moaeidi et al., “Protective role of silymarin and deferoxamine against iron dextran-induced renal iron deposition in male rats,” International Journal of Preventive Medicine, vol. 4, no. 3, pp. 286–292, 2013.
View at: Google Scholar
M. Amiri, P. Motamedi, L. Vakili et al., “Beyond the liver protective efficacy of silymarin; bright renoprotective effect on diabetic kidney disease,” Journal of Nephropharmacology, vol. 3, no. 2, pp. 25-26, 2014.
View at: Google Scholar
J. Tan, J. Hu, Y. He, and F. Cui, “Protective role of silymarin in a mouse model of renal ischemia–reperfusion injury,” Diagnostic Pathology, vol. 10, no. 1, p. 198, 2015.
View at: Publisher Site | Google Scholar
H. Zamani and A. Moradshahi, “Synthesis and coating of nanosilver by vanillic acid and its effects on Dunaliella salina Teod,” Molecular Cell Biology Research Communications, vol. 2, no. 3, pp. 47–55, 2013.
View at: Google Scholar
G. Karimi, M. Vahabzadeh, P. Lari et al., “Silymarin, a promising pharmacological agent for treatment of diseases,” Iranian Journal of Basic Medical Sciences, vol. 14, no. 4, pp. 308–317, 2011.
View at: Google Scholar
X. Zhang, Z. Liu, W. Shen, and S. Gurunathan, “Silver nanoparticles: synthesis, characterization, properties, applications, and therapeutic approaches,” International Journal of Molecular Sciences, vol. 17, no. 9, pp. 1534–1543, 2016.
View at: Publisher Site | Google Scholar
H. Jans, X. Liu, L. Austin, G. Maes, and Q. Huo, “Dynamic light scattering as a powerful tool for gold nanoparticle bioconjugation and biomolecular binding studies,” Analytical Chemistry, vol. 81, no. 22, pp. 9425–9432, 2009.
View at: Publisher Site | Google Scholar
J. D. Bancroft and A. Stevens, “The haematoxylin and eosin,” in Theory and Practice of Histological Techniques, pp. 126–138, Churchill Livingstone, London, UK, 6th edition, 1996.
View at: Google Scholar
W. G. Armitage and G. Y. Berry, Statistical Methods, Iowa State University, Ames, IA, USA, 7th edition, 1987.
F. A. Almutairi, H. A. El Rabey, A. I. Alalawy et al., “Application of chitosan/alginate nanocomposite incorporated with phycosynthesized iron nanoparticles for efficient remediation of chromium,” Polymers, vol. 13, no. 15, p. 2481, 2021.
View at: Publisher Site | Google Scholar
J. K. Patra, G. Das, L. F. Fraceto et al., “Nano based drug delivery systems: recent developments and future prospects,” Journal of Nanobiotechnology, vol. 16, no. 1, p. 71, 2018.
View at: Publisher Site | Google Scholar
R. Vivek, T. Ramar, K. Muthuchelian et al., “Green biosynthesis of silver nanoparticles from Annona squamosa leaf extract and its in vitro cytotoxic effect on MCF-7 cells,” Process Biochemistry, vol. 47, no. 12, pp. 2405–2410, 2012.
View at: Publisher Site | Google Scholar
J. M. Ashraf, M. A. Ansari, H. M. Khan et al., “Green synthesis of silver nanoparticles and characterization of their inhibitory effects on AGEs formation using biophysical techniques,” Science Reports, vol. 2, no. 6, p. 20414, 2016.
View at: Google Scholar

Copyright

Copyright © 2023 Haddad A. El Rabey et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

667

Downloads

348

Citations

International Journal of Polymer Science

Silymarin and Vanillic Acid Silver Nanoparticles Alleviate the Carbon Tetrachloride-Induced Nephrotoxicity in Male Rats

Abstract

1. Introduction

2. Materials and Methods

2.1. Chemicals and Kits

2.1.1. Synthesis of AgNPs from Vanillic Acid

2.1.2. Characterization of AgNPs

2.2. Animals and Experiment Design

2.3. Blood Collection

2.4. Preparation of Kidney Homogenate

2.5. Biochemical Analysis

2.6. Histological Study

2.7. Statistical Analysis

3. Results and Discussion

3.1. Synthesis and Characterization of AgNPs

3.2. Effect of CCl4-Induced Nephrotoxicity on Renal Function Indices

3.3. Effect of CCl4-Induced Nephrotoxicity on Serum Electrolytes

3.4. Effect of CCl4-Induced Nephrotoxicity on Antioxidants and Total Antioxidant Capacity

3.5. Effect of CCl4-Induced Nephrotoxicity on Lipid Peroxidation as Revealed by MDA Level

3.6. Effect of CCl4-Induced Nephrotoxicity on IL-1 and CYP-450 Levels

3.7. Histopathology

4. Conclusion

Abbreviations

Data Availability

Conflicts of Interest

Acknowledgment

Supplementary Materials

References

Copyright

3.2. Effect of CCl₄-Induced Nephrotoxicity on Renal Function Indices

3.3. Effect of CCl₄-Induced Nephrotoxicity on Serum Electrolytes

3.4. Effect of CCl₄-Induced Nephrotoxicity on Antioxidants and Total Antioxidant Capacity